tocophersolan has been researched along with raloxifene hydrochloride in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Buchanan, CM; Caflisch, GB; Edgar, KJ; Large, SE; Lightner, JW; Little, JL; Rice, PJ; Ruble, KM; Wacher, VJ; Wempe, MF; Wright, C | 1 |
| Ahmed, OAA; Alhakamy, NA; Fahmy, UA | 1 |
| Du, X; Gao, N; Song, X | 1 |
3 other study(ies) available for tocophersolan and raloxifene hydrochloride
| Article | Year |
|---|---|
Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Availability; Biological Transport; Caco-2 Cells; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Drug Carriers; Humans; Male; Mass Spectrometry; Polyethylene Glycols; Raloxifene Hydrochloride; Rats; Rats, Inbred Strains; Rhodamine 123; Surface-Active Agents; Vitamin E | 2009 |
Vitamin E TPGS based transferosomes augmented TAT as a promising delivery system for improved transdermal delivery of raloxifene.
Topics: Administration, Cutaneous; Animals; Anticarcinogenic Agents; Breast Neoplasms; Drug Carriers; Female; Humans; MCF-7 Cells; Raloxifene Hydrochloride; Rats, Wistar; Selective Estrogen Receptor Modulators; Skin Absorption; tat Gene Products, Human Immunodeficiency Virus; Vitamin E | 2019 |
Bioadhesive polymer/lipid hybrid nanoparticles as oral delivery system of raloxifene with enhancive intestinal retention and bioavailability.
Topics: Acrylic Resins; Administration, Oral; Animals; Biological Availability; Caco-2 Cells; Diglycerides; Drug Carriers; Humans; Liposomes; Nanoparticles; Raloxifene Hydrochloride; Rats; Selective Estrogen Receptor Modulators; Vitamin E | 2021 |